CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at $14.68 ($146,800)
- 4 Open-market sale Chief Business Officer sold 400 shares at $20.00 ($8,000)
- 4 Open-market sale Chief Medical Officer sold 4,000 shares at $20.00 ($80,000)
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at $19.08 ($190,800)
- 4 Open-market sale Chief Development Officer sold 7,500 shares at $15.00 ($112,500)
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at $16.00 ($32,000)
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at $14.19 ($141,900)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 650,000 shares at $17.90 ($11,635,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 16 · 301 filings